The bronchodilator drug tiotropium has been suggested to bind an allosteric site on the M3 muscarinic receptor, but its functional relevance is unclear. We hypothesized that binding to this allosteric site would have functional implications for its bronchoprotective effects and its interactions with LABAs. Methods: We used molecular dynamics simulation and contraction studies in bovine and human smooth muscle strips to study the interactions between acetylcholine and tiotropium. Results: Using molecular dynamics, we show that tiotropium binds to the allosteric site and thereby prevents acetylcholine entry into the orthosteric binding pocket. Thus, tiotropium has two receptor binding sites, both of which antagonize acetylcholine action. This resulted in a low (allosteric binding) and high (orthosteric binding) functional affinity of tiotropium in studies of methacholine induced contractions of airway smooth muscle, that were characterized by rapid versus slow kinetics of interaction between methacholine and tiotropium. Antagonism by tiotropium was insurmountable in nature, with methacholine failing to reach maximal response. This behaviour facilitated functional interactions of tiotropium with the β-agonist olodaterol, which substantially potentiated the bronchoprotective effect of tiotropium to a much greater extent than additive. This biphasic behaviour was not observed for glycopyrrolate or atropine. Conclusions: Tiotropium has two binding sites at the M3 receptor that both prevent acetylcholine action, which together with the slow dissociation kinetics contributes to insurmountable antagonism and enhanced functional interactions with β-agonists.